Drawing for SPECTRUM

USPTO serial 99556966

SPECTRUM

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
KENNEDY, LAURA E
Law office
TMO LAW OFFICE 130

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPECTRUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher Casavale

Christopher Casavale NELSON MULLINS RILEY & SCARBOROUGH LLP301 South College St, Suite 2300Charlotte, NC 28202United States

Goods and services

ClassDescriptionStatusFirst use
010Surgical devices and instruments; disposable medical sterilization pouches, not of paper; catheters and parts and fittings therefor; medical tubing for drainage, transfusion, administering drugs; medical apparatus, namely, implantable ports; implants consisting of artificial materials; biodegradable bone fixation implants; implants comprising natural, non-living materials; surgical implants comprising artificial material and associated surgical instrument sets; surgical implants comprising artificial material; fixation implants comprised of artificial material; orthopedic joint implants made of artificial materials; medical, surgical and orthopedic implants made of artificial materials; implants consisting primarily of artificial materials and also including biological materials; medical devices, namely, intravascular implants comprised of artificial material; medical implants of artificial material in particular for anchoring joint capsule components and ligament tendon structures; medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery; surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; medical and surgical apparatus and instruments, namely, devices used in orthopedic surgery to position surgical instruments, implants and/or patients' limbs; medical devices and apparatus, namely, surgical implants comprised primarily of artificial material and also incorporating processed animal tissue for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; thermoplastic implantable and bioresorbable components, namely, suture anchors and screws, fasteners, staples, and ties, microvascular anastomosis devices, bone and tissue scaffolding; Luer lock tapers and needles for medical use; single-use one, two, and three port medical bags for the preparation, storage and transport of fluids and biopharmaceutical solutions; clamps for surgical use; surgical devices and instruments, namely, intravenous bags, not of paper, sold empty for intravenous therapy; surgical devices and instruments, namely, bags, not of paper, for the collection and disposal of emesis waste, blood storage bags, not of paper, and collection bags, not of paper, for medical purposes; surgical devices and instruments, namely, medical specimen bags, not of paper, for holding body tissue samples for testing purposes; surgical devices and instruments, namely, cannulae; medical tubing for drainage, transfusion, administering drugs, namely, tubing for use with cannulas; surgical devices and instruments, namely, enteral feeding pumps; surgical devices and instruments, namely, tubes for enteral feeding; surgical devices and instruments, namely, vented and non-vented chambers and chamber assemblies for fluid administration, namely, Burette chambers, IV drip chambers, micro drip chambers, UV blocking chambers; implants consisting of artificial materials, namely, subcutaneous valves comprised of artificial materials for implantation; all of the foregoing for use by others in the manufacture and assembly of finished productsACTIVE—
016Plastic film roll stock for packaging pharmaceuticals; all of the foregoing for use by others in the manufacture and assembly of finished productsACTIVE—
017Flexible plastic and silicone tubing used for transport of liquids and biologicals for use in the pharmaceutical and medical industries; all of the foregoing for use by others in the manufacture and assembly of finished productsACTIVE—
035Regulatory submission management, namely, assisting others in preparing and filing applications and reports for medical devices with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approvalACTIVE—
039Warehousing servicesACTIVE—
040Custom manufacturing of plastic parts, plastic components, sub-assemblies and finished products in the aerospace, consumer, defense, precision industrial and medical marketsACTIVE—
042New product design services; product development; tool design, tool management systems design services; providing quality assurance services in the field of plastic parts, plastic components, sub-assemblies and finished products in the aerospace, consumer, defense, precision industrial and medical markets; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of plastic parts, plastic components, sub-assemblies and finished products in the aerospace, consumer, defense, precision industrial and medical marketsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Oct 27, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 27, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
May 27, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 24, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 22, 2026DOCKASSIGNED TO EXAMINER—
Apr 10, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2026TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Feb 3, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance